Publications

The WMAS produces and contributes to a range of medicines-related publications for healthcare professionals and members of the public.


Monkeypox Advice

A separate monkeypox page has been created to house information and advice for healthcare professionals regarding human monkeypox infections.


National COVID-19 treatment Patient Group Directions (PGDs)

The national COVID-19 treatment antivirals PGD templates have been moved to the PGD templates and guidance page.


Ukrainian Medicines Resources

Healthcare professionals can access information to help identify and translate medication details for Ukrainian refugees via our recent blog post.


UKMi Medicines Q&As

Medicines Q&As are produced by UKMi pharmacists throughout the UK, and provide evidence-based, and quality controlled answers to common or unusual enquiries made to Medicines Information services.

UKMi Q&As that have been produced by and are maintained by the WMAS (the specialist UKMI centre for porphyria and complementary medicine) are listed below. These and all current UKMi Q&As are available on the Specialist Pharmacy Services website.

Turmeric: considering its safety and interactions

How should medicines be dosed in children who are obese?

What is the risk of GI bleeding with SSRIs?

How should intravenous potassium chloride be administered in adults?

Metformin for hirsutism and acne in polycystic ovary syndrome


Porphyria

Medicines that are considered safe for use in the acute porphyrias

Using haem arginate (human hemin) in acute porphyria attacks

Travel – a guide for people with acute porphyria (available in Welsh)

Prescribing restrictions in non-acute cutaneous porphyria (available in Welsh)

Safety of topical medicines in porphyria

Acne treatment in those with acute porphyria (available in Welsh)

Safety of dental medicines in acute porphyria 

Making safe medicine choices during general anaesthesia and surgery in acute porphyria


Cardiff & Vale UHB prescribing resources

Good Prescribing Guide and INFORM Formulary

The Good Prescribing Guide is available on the microguide app via iTunes and Google play store

The Guide is intended to supplement the British National Formulary and Cardiff and Vale INFORM Formulary and to provide information on local practices within the University Health Board. The guidelines are intended for adult secondary care practice. The Department of Child Health in Cardiff and Vale University Health Board produce Clinical Guidelines for use in paediatrics.


Other publications

This medicines update in Archives of Disease in Childhood – Education and Practice reviewed international practices for the administration of aminoglycosides by intravenous injection or infusion. It questions if we could use IV injection more in certain circumstances. It was adapted from a review produced by WMIC for the Neonatal and Paediatric Pharmacy Group (NPPG):

Manning A, Burgess A. Aminoglycoside administration in paediatrics: a literature search comparing international practices of intravenous injection or intravenous infusion. Arch Dis Child Educ Pract Ed. 2024; Published Online First: 09 April 2024. doi: 10.1136/archdischild-2024-326924

The following letter to the editor highlights three cases of COVID-19 “rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy from the cohort of patients treated by the National Antiviral Service (NAVS):

Coulson JM, Adams A, Gray LA, Evans A. COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy. J Infect. 2022; S0163-4453(22)00363-2. Online ahead of print. doi: 10.1016/j.jinf.2022.06.011

The following article was adapted from a review commissioned and written by the WMIC for the Neonatal and Paediatric Pharmacists Group:

McArtney R, Bailey A, Champion H. What is a ketogenic diet and how does it affect the use of medicines? Arch Dis Child Educ Pract Ed. 2017; 102:194-9.

In conjunction with the Department of Biochemistry and Immunology, University Hospital of Wales, WMIC has  published two articles on safe prescribing in the acute porphyrias:

Lockett CD and Badminton MN.  Safe prescribing in the autosomal dominant acute porphyrias: a practical approach: Part I. Adverse Drug Reaction Bulletin.  August 2015; No. 293: pp. 1131 – 1134

Lockett CD and Badminton MN.  Safe prescribing in the autosomal dominant acute porphyrias: a practical approach: Part II. Adverse Drug Reaction Bulletin.  October 2015; No. 294: pp. 1135 – 1138


Change history

17 Apr 24

Aminoglycosides article details added.

28 Feb 24

Broken link updated.

03 Oct 23

Welsh translation of ‘Travel – a guide for people with acute porphyria’ uploaded.

02 Oct 23

Latest version of ‘Travel – a guide for people with acute porphyria’ uploaded.

28 Sept 23

Welsh translation of ‘Prescribing restrictions in non-acute cutaneous porphyria’ uploaded.

19 Sept 23

Welsh translation of ‘Acne treatment in those with acute porphyria’ uploaded.

22 Aug 23

Latest update of ‘Acne treatment in those with acute porphyria’ uploaded.

05 Jul 23

Links to porphyria Q&As updated.

07 Sep 22

National COVID-19 treatment PGD templates moved to NAVS healthcare professionals page.

01 Jul 22

National COVID-19 treatment PGD templates updated.

22 Jun 22

COVID-19 “Rebound” article added. Links to articles on SPS website updated.

14 Jun 22

Monkeypox advice added.

21 Apr 22

Ukrainian Medicines Resources added.

30 Mar 22

National COVID-19 treatment PGD templates updated.

09 Feb 22

Paxlovid PGD added.

31 Jan 22

Sotrovimab PGD template updated.

07 Jan 22

Molnupiravir PGD and sotrovimab PGD template updated.

17 Dec 21

Sotrovimab PGD template added and Ronapreve PGD template updated.

15 Dec 21

National COVID-19 treatment PGD templates added.

24 Sep 21

COVID-19 Vaccine advice updated.

10 Sep 21

Advice on COVID-19 Vaccine third primary dose for immunosuppressed individuals added

Cymraeg